Compare Ecolab Inc. (ECL) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs Oscar Health Inc — how do they compare? Ecolab Inc. trades at $280.57 (market cap $79.79B), while Oscar Health Inc trades at $29.23 (market cap $8.63B). The key difference: Ecolab Inc. is far larger — about 9.2× Oscar Health Inc's market cap, and Ecolab Inc. pays a 1.03% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| ECL | OSCR | |
|---|---|---|
Market Cap | $79.79B | $8.63B |
Sector | Consumer Cyclical | Health |
52-Week High | $308.35 | $32.18 |
52-Week Low | $245.73 | $10.85 |
Enterprise Value | $88.57B | $4.99B |
Dividend Yield | 1.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ECL trades at $281.17, down 1.14% on the day, with a bullish technical signal from moving averages and strong institutional interest. The company reported Q2 2026 EPS of $2.09, beating estimates, and raised full-year guidance to $8.05-$8.25. Revenue growth remains steady at 5% organic, supported by pricing gains and volume increases. Valuation ratios are elevated with a P/E of 38.21, reflecting premium pricing for consistent performance.
Outlook is positive with a consensus price target of $327.90, implying 16.6% upside. Risks include high valuation sensitivity and rising input costs. The stock offers growth potential from digital expansion and recent CoolIT acquisition, but investors should monitor margin pressures and debt levels.
Oscar Health (OSCR) trades at $29.11, up 5.2% with strong recent earnings momentum, beating estimates in Q1 and Q2 2026. The stock shows bearish technical signals but benefits from record profitability and raised 2026 guidance. Revenue surged 70% to $4.9 billion in H1 2026, with net income turning positive at $551 million versus a 2025 loss. Valuation remains attractive with P/S of 0.53, suggesting potential undervaluation versus sector peers.
Outlook is positive given membership growth and cost discipline, but risks include medical cost volatility and competitive pressures. Analyst consensus price target of $32.50 implies 12% upside, though technical resistance near $30 may limit near-term gains. Execution on guidance and sustained margin expansion are key catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
